CD8A and neoplasm: Lymphocytes infiltrate into tumor microenvironment of cancer patients and the presence of higher number of cytotoxic CD8+ T cells in solid tumors is associated with improved survival of patients with breast cancer, renal cell carcinoma, melanoma, and ovarian cancer4,5.